1993
DOI: 10.1021/ja00072a058
|View full text |Cite
|
Sign up to set email alerts
|

Direct design of a potent non-peptide fibrinogen receptor antagonist based on the structure and conformation of a highly constrained cyclic RGD peptide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
54
0

Year Published

1995
1995
2007
2007

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 97 publications
(56 citation statements)
references
References 0 publications
2
54
0
Order By: Relevance
“…fibronectin, vitronectin and fibrinogen) adhesion. In addition, RGD peptides can inhibit platelet aggregation mediated by the platelet receptor GP IIb/IIIa with fibrinogen (1, 2). Therefore, RGD peptides and peptidomimetics have been investigated as potential antithrombic agents (3).…”
mentioning
confidence: 99%
“…fibronectin, vitronectin and fibrinogen) adhesion. In addition, RGD peptides can inhibit platelet aggregation mediated by the platelet receptor GP IIb/IIIa with fibrinogen (1, 2). Therefore, RGD peptides and peptidomimetics have been investigated as potential antithrombic agents (3).…”
mentioning
confidence: 99%
“…Eight compounds turned out to be weak or inactive ligands (6,7,9,15,30,33,36,37). The conformations of most of the compounds have been conÐrmed by X-ray structure determination (1, 9È11, 16,19,21,23,28,29,35), NMR spectroscopy (3È6, 12, 13, 17, 20, 22, 26, 27, 30È32, 34, 36) or modelling studies (7,8,14,24,33,37). Surprisingly, to the best of our knowledge, there is only one example (compound 28) where the predicted and the experimentally determined structure of the protein (thrombin) in complex with the ligand was published.28 The importance of peptidomimetics for peptide research is not questioned.…”
mentioning
confidence: 99%
“…After initial attempts with 2-azepinones [70], extensive investigations on differently substituted 1,4-benzodiazepine non-peptide analogues were carried out. Several potent peptidomimetics were discovered, as exemplified here by the orally active α IIb β 3 antagonist 13 [71,72]. A similar approach led to the identification of non-peptide α V β 3 antagonists, such as 14, revealing the versatility of the benzodiazepine nucleus as a Gly-Asp mimetic [73,74].…”
Section: β-Turn-based Peptidomimetics As Antagonists Of Integrinsmentioning
confidence: 99%